Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,466
Total Claims
$1.8M
Drug Cost
1,392
Beneficiaries
$1,268
Cost/Patient
Risk Score Breakdown 25/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+536%
Opioid rate vs peers
15.7% vs 2.5% avg
+12%
Cost per patient vs peers
$1,268 vs $1,128 avg
+58%
Brand preference vs peers
13.3% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 536% above the average for General Practice providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
15.7%
Opioid Rate
3,220
Opioid Claims
$126K
Opioid Cost
15.6%
Long-Acting Rate
Brand vs Generic
Brand: 2,708 claims · $1.4M
Generic: 17,693 claims · $398K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 179 | $209K |
| Apixaban | 144 | $122K |
| Empagliflozin | 114 | $117K |
| Fluticasone/Umeclidin/Vilanter | 101 | $79K |
| Dapagliflozin Propanediol | 79 | $69K |
| Dulaglutide | 51 | $66K |
| Tirzepatide | 58 | $64K |
| Varicella-Zoster Ge/As01b/Pf | 301 | $62K |
| Mirabegron | 82 | $50K |
| Budesonide/Formoterol Fumarate | 96 | $45K |
| Hydrocodone/Acetaminophen | 1,539 | $45K |
| Brexpiprazole | 22 | $33K |
| Sitagliptin Phosphate | 24 | $26K |
| Pregabalin | 499 | $23K |
| Tiotropium Bromide | 27 | $22K |
Prescribing Profile
Patient Profile
70
Avg Age
62%
Female
1.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data